NFKB1 and Duchenne muscular dystrophy: demonstrated that, in the dystrophic muscle environment of the DMD model, a high concentration of inflammatory mediators such as TNF-α acts as stimulants for the transcription factor NF-κB, thus activating the NF-κB signaling pathway and promoting muscle degeneration.